P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis.
Yamakuchi
Munekazu
M
Department of Medicine, Aab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA. munekazu_yamakuchi@urmc.rochester
Lotterman
Craig D
CD
Bao
Clare
C
Hruban
Ralph H
RH
Karim
Baktiar
B
Mendell
Joshua T
JT
Huso
David
D
Lowenstein
Charles J
CJ
D000818:Animals; D051784:Aryl Hydrocarbon Receptor Nuclear Translocator / Q000378:metabolism*; D001483:Base Sequence; D015687:Cell Hypoxia; D015972:Gene Expression Regulation, Neoplastic; D045325:HCT116 Cells; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D035683:MicroRNAs / Q000235:genetics*; D009369:Neoplasms / Q000098:blood supply* / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction; D014158:Transcription, Genetic; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism*; D023041:Xenograft Model Antitumor Assays
C497396:ARNT protein, human; C549045:MIRN107 microRNA, human; D035683:MicroRNAs; C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53; D051784:Aryl Hydrocarbon Receptor Nuclear Translocator